Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma

M Shimoyama · British Journal of Haematology · 1991 · 1.6K citations

Medicine, Hematology, Oncology +16

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

G-Q Chen, Jing Zhu, XG Shi et al. · Blood · 1996 · 852 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Antibodies to adult t‐cell leukemia‐virus‐associated antigen (atla) in sera from patients with atl and controls in japan: A nation‐wide sero‐epidemiologic study

Yorio Hinuma, Haruko Komoda, Toru Chosa et al. · International Journal of Cancer · 1982 · 592 citations

Life Sciences, Immunology, Infectious Diseases +9

Treatment of Adult T-Cell Leukemia–Lymphoma with a Combination of Interferon Alfa and Zidovudine

Parkash S. Gill, William J. Harrington, Mark H. Kaplan et al. · New England Journal of Medicine · 1995 · 378 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

Abundant Tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes

Emmanuel Hanon, Sarah E. Hall, Graham P. Taylor et al. · Blood · 2000 · 275 citations

Life Sciences, Immunology, Molecular Biology +16